Skip to main content
. 2012 Nov 27;11(2):159–170. doi: 10.2165/11591200-000000000-00000

Table II.

Table II

Absolute level at cycle three and intra-individual absolute change from baseline to cycle three in activation markers in women (n = 29) during treatment with estradiol valerate/dienogest (E2V/DNG) or ethinylestradiol/levonorgestrel (EE/LNG).[n = 28]